Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Ghady Haidar, Steven Thomas, Paul Loubet, Ross I. Baker et autres
0 citations
Repository@Nottingham (University of Nottingham)